July/August 2022 Billing and Coding Article Updates
Billing and Coding Articles
Billing and Coding: Botulinum Toxins (A52848)
Based on comments received, ICD-10-CM codes N39.41 and N39.46 have been added to the Group 4 ICD-10 code list and ICD-10 code G43.111 has been added to the Group 11 ICD-10-code list effective for dates of service on or after 7/21/2022.
Billing and Coding: Complex Drug Administration Coding (A58620)
Effective 7/21/2022, patisiran (Onpattro™) (J0222) has been removed from the Infusions Non-Chemotherapy table and the CPT/HCPCS Codes Group 2. Effective for dates of service on or after 9/4/2022, tezepelumab-ekko (Tezspire™) (J2356) has been added to the Subcutaneous and Intramuscular Injection Non-Chemotherapy table and the CPT/HCPCS Codes Group 1.
Billing and Coding: Molecular Pathology Procedures (A56199)
Correction: ICD-10-CM diagnosis code, C56.3 is effective for services rendered on or after 10/1/2021.
Billing and Coding: Outpatient Physical and Occupational Therapy Services (A56566)
Under General Documentation Requirements, added, Refer to CMS guidance on billing by PTAs and OTAs under Billing Examples Using CQ/CO Modifiers for Services Furnished In Whole or In Part by PTAs and OTAs.